News
Nuvig, Maze, and Antag close funding rounds In other financing news this week, immunomodulation therapy developer Nuvig Therapeutics ... and Nuvig's preclinical pipeline. NVG-2089 is designed ...
Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...
What potential does the company’s pipeline hold for addressing unmet medical needs? Contineum Therapeutics’ pipeline holds significant potential for addressing unmet medical needs across ...
It covers the Meningioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Meningioma pipeline therapeutics assessment by product type, stage ...
What potential does the company’s pipeline hold for addressing unmet medical needs? Contineum Therapeutics’ pipeline holds significant potential for addressing unmet medical needs across several ...
The company also has several candidates in its pipeline as can be seen above. United Therapeutics is trying to position Tyvaso to treat idiopathic pulmonary fibrosis, where it would have Orphan ...
Investing.com -- Eli Lilly and Company (NYSE:LLY) is expanding its neuroscience pipeline through the acquisition of SiteOne Therapeutics in a deal worth up to $1 billion, deepening its bet on non ...
The strategic partnership is likely to diversify CRISPR Therapeutics’ pipeline by adding Sirius’s lead candidate, SRSD107, a next-generation, long-acting siRNA therapy, which is being ...
It also covers the Peritoneal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in ...
It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results